{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T18:22:17Z","timestamp":1746469337160},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,26]]},"DOI":"10.7759\/cureus.21650","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T03:16:22Z","timestamp":1643253382000},"source":"Crossref","is-referenced-by-count":3,"title":["Sibutramine-Induced Nonischemic Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Meet S","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeel K","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronak","family":"Bharucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tirth","family":"Talati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/157015912799362788","article-title":"Sibutramine effects on central mechanisms regulating energy homeostasis","volume":"10","author":"Ara\u00fajo JR","year":"2012","unstructured":"Ara\u00fajo JR, Martel F. Sibutramine effects on central mechanisms regulating energy homeostasis. Curr Neuropharmacol. 2012, 10:49-52. 10.2174\/157015912799362788","journal-title":"Curr Neuropharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-s205","article-title":"Sibutramine on cardiovascular outcome","volume":"34 Suppl 2","author":"Scheen AJ","year":"2011","unstructured":"Scheen AJ. Sibutramine on cardiovascular outcome. Diabetes Care. 2011, 34 Suppl 2:S114-9. 10.2337\/dc11-s205","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James WP","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, et al.. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010, 363:905-17. 10.1056\/NEJMoa1003114","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5580\/2c02","article-title":"A case report on sibutramine induced cardiomyopathy","volume":"10","author":"Ibrahim O","year":"2012","unstructured":"Ibrahim O, Maskan O, Liang T, Hassan H, Rahman M. A case report on sibutramine induced cardiomyopathy. Int J Cardiol. 2012, 10:10.5580\/2c02","journal-title":"Int J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.06.012","article-title":"Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy","volume":"3","author":"Shore S","year":"2015","unstructured":"Shore S, Grau-Sepulveda MV, Bhatt DL, et al.. Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy. JACC Heart Fail. 2015, 3:906-16. 10.1016\/j.jchf.2015.06.012","journal-title":"JACC Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/11584800-000000000-00000","article-title":"Cardiovascular risk-benefit profile of sibutramine","volume":"10","author":"Scheen AJ","year":"2010","unstructured":"Scheen AJ. Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc Drugs. 2010, 10:321-34. 10.2165\/11584800-000000000-00000","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02574.x","article-title":"QT interval prolongation associated with sibutramine treatment","volume":"61","author":"Harrison-Woolrych M","year":"2006","unstructured":"Harrison-Woolrych M, Clark DW, Hill GR, Rees MI, Skinner JR. QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol. 2006, 61:464-9. 10.1111\/j.1365-2125.2006.02574.x","journal-title":"Br J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84727-sibutramine-induced-nonischemic-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:01Z","timestamp":1707507421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84727-sibutramine-induced-nonischemic-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.21650","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}